HGG-36. HIF-2: A NEW DRUG TARGET IN PEDIATRIC HIGH-GRADE GLIOMA WITH PROMISING PRECLINICAL RESULTS

Authors: Quentin Fuchs, Marina Pierrevelcin, Christophe Papin, Monique Dontenwill, Natacha Entz-Werlé

Published: 2020-12-04

DOI: 10.1093/neuonc/noaa222.317

Source: Full article


Abstract

Abstract